Serotonergic and GABAergic neurons in the medial rostral ventral medulla express κ-opioid receptor immunoreactivity

Neuroscience

Volumn 90, Issue 1, 1999, Pages 229-234

  Kalyuzhny, A E ^a   Wessendorf, M W ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

Author keywords

5 HT; Analgesia; Confocal microscopy; Immunofluorescence double labeling; Nucleus raphe magnus

Indexed keywords

4 AMINOBUTYRIC ACID RECEPTOR; KAPPA OPIATE RECEPTOR;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CONFOCAL MICROSCOPY; IMMUNOREACTIVITY; NERVE PROJECTION; NONHUMAN; PRIORITY JOURNAL; RAT; SEROTONINERGIC NERVE CELL; SPINAL CORD;

ANIMALS; GAMMA-AMINOBUTYRIC ACID; IMMUNOHISTOCHEMISTRY; MEDULLA OBLONGATA; PONS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, OPIOID, KAPPA; SEROTONIN;

EID: 0032974181     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-4522(98)00376-5     Document Type: Article

References (32)

1. Arvidsson U., Dado R.J., Law P.-Y., Loh H.H., Elde R., Wessendorf M.W. Delta (δ)-opioid receptor immunoreactivity: distribution in brain stem and spinal cord and relationship to biogenic amines and enkephalin. J. Neurosci. 15:1995;1215-1235.
2. Arvidsson U., Riedl M., Chakrabarti S., Lee J.-H., Nakano A.H., Dado R., Loh H.H., Law P.-Y., Wessendorf M.W., Elde R. Distribution and targeting of a μ-opioid receptor (MOR1) in brain and spinal cord. J. Neurosci. 15:1995;3328-3341.
3. Arvidsson U., Riedl M., Chakrabarti S., Vulchanova L., Lee J.-H., Nakano A.H., Lin X., Loh H.H., Law P.-Y., Wessendorf M.W.et al. The κ-opioid receptor (KOR1) is primarily postsynaptic: combined immunohistochemical localization of the receptor and endogenous opioids. Proc. natn. Acad. Sci. U.S.A. 92:1995;5062-5066.
4. Dahlström A., Fuxe K. Evidence for the existence of monoamine neurons in the central nervous system - I. Demonstration of monoamines in cell bodies of brain stem neurons. Acta physiol. scand. 62:1964;1-55.
5. Ho B.Y., Takemori A.E. Attenuation of the antinociceptive action of the selective kappa-opioid receptor agonist, U-50,488H, by ICS-205-930. Eur. J. Pharmac. 178:1990;371-373.
6. 3H]serotonin from brain slices and spinal cord synaptosomes of U-50,488H-tolerant and nontolerant mice. J. Pharmac. exp. Ther. 254:1990;8-12.
7. Hoshi K., Ma T., Oh S., Ho I.K. Increased release of excitatory amino acids in rat locus coeruleus in kappa-opioid agonist dependent rats precipitated by nor-binaltorphimine. Brain Res. 753:1997;63-68.
8. Kalyuzhny A.E., Arvidsson U., Wei W., Wessendorf M. μ-Opioid and δ-opioid receptors are expressed in brainstem antinociceptive circuits: studies using immunocytochemistry and retrograde tract-tracing. J. Neurosci. 16:1996;6490-6503.
9. Kalyuzhny A.E., Wessendorf M.W. CNS GABA neurons express the μ-opioid receptor: immunocytochemical studies. NeuroReport. 8:1997;3367-3372.
10. Kalyuzhny A.E., Wessendorf M.W. Relationship of μ- and δ-opioid receptors to GABAergic neurons in the CNS, including antinociceptive brainstem circuits. J. comp. Neurol. 392:1998;528-547.
11. Kunihara M., Ohyama M., Nakano M. Central monoaminergic mechanisms in mice and analgesic activity of spiradoline mesylate, a selective kappa-opioid receptor agonist. Eur. J. Pharmac. 214:1992;111-118.
12. Mansour A., Fox C.A., Meng F., Akil H., Watson S.J. Kappa 1 receptor mRNA distribution in the rat CNS: comparison to kappa receptor binding and prodynorphin mRNA. Molec. cell. Neurosci. 5:1994;124-144.
13. Mansour A., Khachaturian H., Lewis M.E., Akil H., Watson S.J. Autoradiographic differentiation of mu, delta, and kappa opioid receptors in the rat forebrain and midbrain. J. Neurosci. 7:1987;2445-2464.
14. Mansour A., Khachaturian H., Lewis M.E., Akil H., Watson S.J. Anatomy of CNS opioid receptors. Trends Neurosci. 11:1988;308-314.
15. McFadzean I., Lacey M.G., Hill R.G., Henderson G. Kappa opioid receptor activation depresses excitatory synaptic input to rat locus coeruleus neurons in vitro. Neuroscience. 20:1987;231-239.
16. Meng F., Xie G.X., Thompson R.C., Mansour A., Goldstein A., Watson S.J., Akil H. Cloning and pharmacological characterization of a rat kappa opioid receptor. Proc. natn. Acad. Sci. U.S.A. 90:1993;9954-9958.
17. Millhorn D.E., Hokfelt T., Seroogy K., Oertel W., Verhofstad A.A., Wu J.Y. Immunohistochemical evidence for colocalization of gamma-aminobutyric acid and serotonin in neurons of the ventral medulla oblongata projecting to the spinal cord. Brain Res. 410:1987;179-185.
18. Millhorn D.E., Hokfelt T., Seroogy K., Verhofstad A.A. Extent of colocalization of serotonin and GABA in neurons of the ventral medulla oblongata in rat. Brain Res. 461:1988;169-174.
19. Minami M., Toya T., Katao Y., Maekawa K., Nakamura S., Onogi T., Kaneko S., Satoh M. Cloning and expression of a cDNA for the rat kappa-opioid receptor. Fedn Eur. biochem. Socs Lett. 329:1993;291-295.
20. 3H]5-hydroxytryptamine release are not related to their antinociceptive action. Eur. J. Pharmac. 272:1995;51-56.
21. Mugnaini E. and Oertel W. H. (1985) An atlas of the distribution of GABAergic neurons and terminals in the rat CNS as revealed by GAD immunohistochemistry. In Handbook of Chemical Neuroanatomy (eds Bjorklund A. and Hökfelt T.), Vol. 4, pp. 436-608. Elsevier, Amsterdam.
22. Nishi M., Takeshima H., Fukuda K., Kato S., Mori K. cDNA cloning and pharmacological characterization of an opioid receptor with high affinities for kappa-subtype-selective ligands. Fedn Eur. biochem. Socs Lett. 330:1993;77-80.
23. Pan Z.Z., Tershner S.A., Fields H.L. Cellular mechanism for anti-analgesic action of agonists of the kappa-opioid receptor. Nature. 389:1997;382-385.
24. Pan Z.Z., Wessendorf M.W., Williams J.T. Modulation by serotonin of the neurons in rat nucleus raphe magnus in vitro. Neuroscience. 54:1993;421-429.
25. Pinnock R.D. A highly selective kappa-opioid receptor agonist, CI-977, reduces excitatory synaptic potentials in the rat locus coeruleus in vitro. Neuroscience. 47:1992;87-94.
26. Schmued L.C., Fallon J.H. Fluoro-Gold: a new fluorescent retrograde axonal tracer with numerous unique properties. Brain Res. 377:1986;147-154.
27. Skageberg G., Bjorklund A. Topographic principles in the spinal projections of serotonergic and non-serotonergic brainstem neurons in the rat. Neuroscience. 15:1985;445-480.
28. Steinbusch H.W. Distribution of serotonin-immunoreactivity in the central nervous system of the rat - cell bodies and terminals. Neuroscience. 6:1981;557-618.
29. Tempel A., Zukin R.S. Neuroanatomical patterns of the mu, delta, and kappa opioid receptors of rat brain as determined by quantitative in vitro autoradiography. Proc. natn. Acad. Sci. U.S.A. 84:1987;4308-4312.
30. Vonvoigtlander P.F., Lewis R.A., Neff G.L. Kappa opioid analgesia is dependent on serotonergic mechanisms. J. Pharmac. exp. Ther. 231:1984;270-274.
31. Wessendorf M.W. Fluoro-Gold: composition, and mechanism of uptake. Brain Res. 553:1991;135-148.
32. Yasuda K., Raynor K., Kong H., Breder C.D., Takeda J., Reisine T., Bell G.I. Cloning and functional comparison of kappa and delta opioid receptors from mouse brain. Proc. natn. Acad. Sci. U.S.A. 90:1993;6736-6740.